Reply to López-Campos <i>et al.</i>: Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect - KIVIRID

Reply to López-Campos <i>et al.</i>: Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect

Authors: David A. Lipson, MeiLan K. Han, Robert Wise, Fernando J. Martinez

Published: 2021-01-14

DOI: 10.1164/rccm.202012-4494le

Source: Full article

Abstract

No abstract found.